Endothelial dysfunction and its treatment in psoriasis patients

Cover Page

Cite item


Goal. To assess the effect of a combined cytostatic therapy and sulodexide on the functional condition of the vascular endothelium in psoriatic patients. Materials and methods. The authors examined 74 patients suffering from psoriasis vulgaris and exudative form of psoriasis. Depending on the treatment option, the patients were subdivided into two groups: Group I (n = 41) receiving a cytostatic therapy and Group II where patients received sulodexide as well. The severity of the endothelium dysfunction was assessed based on laboratory assessments such as nitrogen oxide and endothelin 1 in the blood serum. Results. Prior to the treatment, the level of nitrogen oxide was reduced and endothelin 1 was increased in the blood serum of most patients. Substantial improvement of the pathological process was observed in patients from Group I after the cytostatic therapy (total dose of methotrexate: 100 mg); no normalization of laboratory assessments was observed. In patients from Group II receiving methotrexate (total dose: 40 mg) along with sulodexide, improvement or recovery was observed after the completion of the treatment; endothelium dysfunction was normalized. Conclusion. The inclusion of sulodexide in a complex therapy normalizes endothelial dysfunction in case of psoriasis and reduces the dose and duration of methotrexate treatment.

About the authors

Yu. M. Shtoda

Saratov State Medical University named after V.I. Razumovsky

Author for correspondence.
Email: noemail@neicon.ru
Russian Federation

N. A. Slesarenko

Saratov State Medical University named after V.I. Razumovsky

Email: noemail@neicon.ru
Russian Federation

A. L. Bakulev

Saratov State Medical University named after V.I. Razumovsky

Email: al_ba05@mail.ru
Russian Federation

S. R. Utz

Saratov State Medical University named after V.I. Razumovsky

Email: noemail@neicon.ru
Russian Federation

A. N. Platonova

Saratov State Medical University named after V.I. Razumovsky

Email: noemail@neicon.ru
Russian Federation


  1. Kubanova A.A., Martynov A.A., Lesnaya I.N., Kubanov A.A. Organization of the dermatovenerologichesky help: achievements and prospects. Vestn Dermatol Venerol 2008; (1): 4-22.
  2. Vladimirova I.S., Monakhov K.N. Possibilities of enhancement of the efficiency of complex psoriasis treatment Vestn Dermatol Venerol 2010; (2): 58-63.
  3. Gottlieb Alice B., Dann Frank. Comorbidities in Patients with Psoriasis. Am J Med. 2009; Vol. 122 (12): 1150е1-1150е9.
  4. Xobejsh M.M., Moshkalova I.A., Sokolovskiy E.V. Psoriasis. Modern methods of treatment SpB.Sotis.:1999; 70-134.
  5. Langley R.G. Effective and sustainable biologic treatment of psoriasis: what can we learn from new clinical data? JEADV. 2012; 26 (Suppl. 2): 21-29.
  6. Butov Yu.S., Skripkin Yu.K., Ivanov O.L. Dermatovenerology. National management, short edition. M.: GOETAR-Media. 2013; 52.
  7. Sarian E.N. Endothelium dysfunction at patients with a psoriasis and statines. International medical magazine. 2012; (3): 89-93.
  8. Cecchi R., Giomi A., Ciuti M. et al. Increased levels of plasma endothelin-1 in patients with psoriasis. Clin. Chim. Acta. 1994; 226 (1): 113-115.
  9. Furchgott R. F., Zawadski J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980; 288: 373-376.
  10. Krischel V., Bruch Gerharz D., Suschek C. Biphasic effect of exogenous nitric oxide on proliferation and differentiation in skin - derived keratinocytes, but not fibroblasts. J Invest Dermatol 1998; 111: 286-291.
  11. Gavriova N.A., Tishchenko A.L. The impact of sulodexide on the endothelial functional state in patients with diabetes mellitus and diabetic retinopathy Diabetes Mellitus. 2011; (2 ): 66-68.
  12. Creamer D., Sullivan D., Bicknell R., Barker J. Angiogenesis in psoriasis. Angiogenesis. 2002; 5 (1): 231-236.

Copyright (c) 2015 Shtoda Y.M., Slesarenko N.A., Bakulev A.L., Utz S.R., Platonova A.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 60448 от 30.12.2014.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies